Antibody micro arrays are an emerging technology that has the potential to efficiently and quantitatively analyze many proteins in thousands of samples. Therefore, this technology can provide a badly needed mechanism for determining the clinical usefulness of individual or profiles of potential biomarkers. At present, though, antibody micro array analysis lacks the guiding principles, standard procedures, honed laboratory practices, foundational statistics and supporting software to produce quality results on a large scale. Therefore, we have started to develop both the protocols and supporting software (""""""""ProMAT"""""""") specifically for analyzing protein micro array data. The goal of this proposal is to advance antibody micro array to the point that it can be used as a routine tool for clinical biomarker validation. To accomplish this goal, we plan to establish novel protocols for the use of internal and external standards, develop the statistical foundation for evaluating data quality at all stages of data collection and analysis, and develop a sophisticated bioinformatics tool for rapid data analysis, including advanced quality control features. This system will also aid in identifying sources of data variability and will allow for data normalization. We will use an iterative process that cycles through resolving assay requirements, deriving statistical methods and composing prototype software, honing laboratory practices and assay procedures, and evaluating progress through repetitive experimentation that focuses on assessing data quality and reproducibility. At the completion of this work, we will have uncovered guiding principles and requirements for conducting antibody micro array experiments and developed an integrated system for rapidly generating the high quality data required to evaluate the clinical potential of biomarker profiles. ? ? ?

National Institute of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Research Project (R01)
Project #
Application #
Study Section
Biodata Management and Analysis Study Section (BDMA)
Program Officer
Korte, Brenda
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Battelle Pacific Northwest Laboratories
United States
Zip Code
Zangar, Richard C; Bollinger, Nikki; Weber, Thomas J et al. (2011) Reactive oxygen species alter autocrine and paracrine signaling. Free Radic Biol Med 51:2041-7
White, Amanda M; Daly, Don S; Zangar, Richard C (2011) Analysis of high-throughput ELISA microarray data. Methods Mol Biol 694:191-211
Gonzalez, Rachel M; Zhang, Qibin; Zangar, Richard C et al. (2011) Development of a fibrinogen-specific sandwich enzyme-linked immunosorbent assay microarray assay for distinguishing between blood plasma and serum samples. Anal Biochem 414:99-102
Daly, Don Simone; Anderson, Kevin K; Seurynck-Servoss, Shannon L et al. (2010) An internal calibration method for protein-array studies. Stat Appl Genet Mol Biol 9:Article 14
Jin, Hongjun; Zangar, Richard C (2010) Antibody microarrays for high-throughput, multianalyte analysis. Cancer Biomark 6:281-90
Zangar, R C; Daly, D S; White, A M et al. (2009) ProMAT calibrator: A tool for reducing experimental bias in antibody microarrays. J Proteome Res 8:3937-43
White, Amanda M; Collett, James R; Seurynck-Servoss, Shannon L et al. (2009) ELISA-BASE: an integrated bioinformatics tool for analyzing and tracking ELISA microarray data. Bioinformatics 25:1566-7
Servoss, Shannon L; Gonzalez, Rachel; Varnum, Susan et al. (2009) High-Throughput Analysis of Serum Antigens Using Sandwich ELISAs on Microarrays. Methods Mol Biol 520:143-50
Jin, Hongjun; Zangar, Richard C (2009) Protein modifications as potential biomarkers in breast cancer. Biomark Insights 4:191-200
Gonzalez, Rachel M; Seurynck-Servoss, Shannon L; Crowley, Sheila A et al. (2008) Development and validation of sandwich ELISA microarrays with minimal assay interference. J Proteome Res 7:2406-14

Showing the most recent 10 out of 11 publications